{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T17:12:08Z","timestamp":1776532328565,"version":"3.51.2"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16fk0210102h0001, and 17fk0210106h0501"],"award-info":[{"award-number":["16fk0210102h0001, and 17fk0210106h0501"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K09334"],"award-info":[{"award-number":["16K09334"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17fk0210102h0001"],"award-info":[{"award-number":["17fk0210102h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0209615","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T14:43:50Z","timestamp":1545403430000},"page":"e0209615","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2953-6242","authenticated-orcid":true,"given":"Naoki","family":"Kawagishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goki","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuharu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiko","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Sho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuteru","family":"Natsuizaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.24724","article-title":"Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders","volume":"55","author":"K Chayama","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"MS Sulkowski","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00535-016-1162-8","article-title":"Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C","volume":"51","author":"G Suda","year":"2016","journal-title":"J Gastroenterol"},{"key":"ref4","article-title":"Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy","author":"G Suda","year":"2017","journal-title":"J Gastroenterol"},{"key":"ref5","article-title":"Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan","author":"G Suda","year":"2017","journal-title":"J Gastroenterol"},{"key":"ref6","article-title":"Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment","author":"G Suda","year":"2016","journal-title":"Hepatol Res"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.23691","article-title":"Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection","volume":"52","author":"Y Asahina","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/hepr.12393","article-title":"Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy","volume":"45","author":"N Hiramatsu","year":"2015","journal-title":"Hepatol Res"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0168-8278(98)80004-4","article-title":"Host- and disease-specific factors affecting steatosis in chronic hepatitis C","volume":"29","author":"AJ Czaja","year":"1998","journal-title":"J Hepatol"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production","volume":"9","author":"Y Miyanari","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"R Moucari","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2007.10.011","article-title":"Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C","volume":"48","author":"M Vidali","year":"2008","journal-title":"Journal of hepatology"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0607312104","article-title":"Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis","volume":"104","author":"K Moriishi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"ref14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000333253","article-title":"Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species","volume":"81","author":"H Fujinaga","year":"2011","journal-title":"Oncology"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1128\/JVI.02727-13","article-title":"Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation","volume":"88","author":"GH Syed","year":"2014","journal-title":"J Virol"},{"issue":"45","key":"ref16","doi-asserted-by":"crossref","first-page":"37481","DOI":"10.1074\/jbc.M506412200","article-title":"Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production","volume":"280","author":"M Korenaga","year":"2005","journal-title":"The Journal of biological chemistry"},{"issue":"48","key":"ref17","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.3748\/wjg.v11.i48.7591","article-title":"Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A","volume":"11","author":"Y Cheng","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jmv.24692","article-title":"Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection","volume":"89","author":"Y Tsukuda","year":"2017","journal-title":"J Med Virol"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","article-title":"Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis","volume":"16","author":"G Perlemuter","year":"2002","journal-title":"FASEB J"},{"issue":"21","key":"ref20","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"PM Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1388-1981(00)00123-2","article-title":"Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL","volume":"1488","author":"T Hevonoja","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study","volume":"34","author":"RC Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3350\/cmh.2014.20.1.38","article-title":"The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients","volume":"20","author":"HJ Jung","year":"2014","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.510250632","article-title":"Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C","volume":"25","author":"E Shinohara","year":"1997","journal-title":"Hepatology"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"T Karlas","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng.2926","article-title":"Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk","volume":"46","author":"OL Holmen","year":"2014","journal-title":"Nat Genet"},{"issue":"3","key":"ref27","first-page":"175","article-title":"PNPLA3 as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum","volume":"4","author":"H Salameh","year":"2016","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.27556","article-title":"Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity","volume":"61","author":"S Sookoian","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.4238\/2014.December.4.9","article-title":"Correlation between MTP -493G>T polymorphism and non-alcoholic fatty liver disease risk: a meta-analysis","volume":"13","author":"L Li","year":"2014","journal-title":"Genet Mol Res"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5551\/jat.15792","article-title":"Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version","volume":"20","author":"T Teramoto","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"507245","DOI":"10.1155\/2015\/507245","article-title":"Circulating malondialdehyde-modified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes","volume":"2015","author":"K Fujihara","year":"2015","journal-title":"J Diabetes Res"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jmv.24950","article-title":"Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b","volume":"90","author":"N Ogasawara","year":"2018","journal-title":"J Med Virol"},{"key":"ref33","article-title":"Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2","author":"K Ohya","year":"2018","journal-title":"J Med Virol"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1872-034X.2010.00692.x","article-title":"Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy","volume":"40","author":"M Kurosaki","year":"2010","journal-title":"Hepatol Res"},{"issue":"39","key":"ref35","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.3748\/wjg.v13.i39.5180","article-title":"Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C","volume":"13","author":"A Tanaka","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.27424","article-title":"Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients","volume":"61","author":"EG Meissner","year":"2015","journal-title":"Hepatology"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"e0163644","DOI":"10.1371\/journal.pone.0163644","article-title":"Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment","volume":"11","author":"S Hashimoto","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1872-034X.2011.00838.x","article-title":"Cholesterol and chronic hepatitis C virus infection","volume":"41","author":"A Honda","year":"2011","journal-title":"Hepatol Res"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1872-034X.2010.00700.x","article-title":"Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver","volume":"40","author":"T Fujino","year":"2010","journal-title":"Hepatol Res"},{"issue":"6","key":"ref40","first-page":"825","article-title":"Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy?","volume":"24","author":"M Nakamuta","year":"2009","journal-title":"Int J Mol Med"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"C Cicognani","year":"1997","journal-title":"Arch Intern Med"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.14218\/JCTH.2017.00021","article-title":"Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review","volume":"5","author":"A Babiker","year":"2017","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/gutjnl-2014-308163","article-title":"Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection","volume":"64","author":"YC Hsu","year":"2015","journal-title":"Gut"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1273042","DOI":"10.1155\/2017\/1273042","article-title":"Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases","volume":"2017","author":"EA Ivanova","year":"2017","journal-title":"Oxid Med Cell Longev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0209615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:34:57Z","timestamp":1588962897000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0209615"}},"subtitle":[],"editor":[{"given":"Umberto","family":"Vespasiani-Gentilucci","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0209615","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]}}}